Heron Therapeutics
HRTX
#8264
Rank
A$0.24 B
Marketcap
$1.63
Share price
-5.36%
Change (1 day)
-18.57%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.76

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.80. In 2022 the company made an earnings per share (EPS) of -$2.65 an increase over its 2021 EPS that were of -$3.45.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.76-33.54%
2022-$2.65-23.11%
2021-$3.45-10%
2020-$3.84-0%
2019-$3.841.21%
2018-$3.79-32.7%
2017-$5.63-19.34%
2016-$6.9854.76%
2015-$4.511.73%
2014-$4.43-16.23%
2013-$5.2991.67%
2012-$2.76-31.45%
2011-$4.03-27.06%
2010-$5.52-43.75%
2009-$9.82-57.33%
2008-$23.01-82.92%
2007-$134.7120.61%
2006-$111.70175.76%
2005-$40.51-21.43%
2004-$51.55100%
2003-$25.78-38.24%
2002-$41.73161.54%
2001-$15.96-106.46%
2000$246.862051.55%
1999$11.47839.73%
1998$1.22-105.48%
1997-$22.30-88.16%
1996-$188.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.99-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.21-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.50 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.41-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.53 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA